STAT
DECEMBER 16, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Fighting back a hyper 6-year-old and his 3-year-old partner in crime as I attempt to write an intro here. My offspring say hello.
The Pharmacist
DECEMBER 16, 2024
The eligible patient cohorts for vaccination under the spring 2025 Covid-19 programme have been confirmed, following recommendations from government advisors. In a letter sent to community pharmacies and others, NHS England announced the spring programme will cover: adults aged 75 years and over; residents in care homes for older adults; and individuals aged six months […] The post Government confirms Covid vaccine eligibility for spring 2025 programme appeared first on The Pharmacist.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 16, 2024
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin. So to nudge it in a better direction, we have planted ourselves in the Pharmalot cafeteria to quaff cups of stimulation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
DECEMBER 16, 2024
On December 13, 2024, Lupin, a global pharmaceutical company, announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH. The move is aimed at strengthening Lupins diabetes portfolio in India. The trademark rights for these brands are set to be transferred to Lupin by March 2025.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
DECEMBER 16, 2024
New treatment could revolutionise care for HAE patients
Pharma Times
DECEMBER 16, 2024
Phase 2a study shows promising antidepressant effects
Express Pharma
DECEMBER 16, 2024
Chronic hand eczema (CHE) is a persistent, inflammatory skin disorder characterised by redness and itching, significantly reducing quality of life (QoL). Although multiple treatments for CHE are available, significant unmet need remains in long-term disease management and symptom control unable to be addressed by the current therapies. Therefore, there is a clear demand for therapies that offer sustained relief, fewer side effects, and improved ease of use, says GlobalData, a leading data and an
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
DECEMBER 16, 2024
Gerresheimer, a system and solution provider and global partner for the pharma, biotech, and cosmetics industries, announced that the US Food and Drug Administration (FDA) has granted SQ Innovation Tentative Approval for Lasix ONYU. This combination product consists of a high-concentration formulation of the diuretic furosemide and the Gerresheimer on-body drug delivery device.
Pharmaceutical Technology
DECEMBER 16, 2024
Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Patent Watch
DECEMBER 16, 2024
When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various tools to find relevant information. Google Patents, with its user-friendly interface and vast database, might seem like an ideal resource. However, there are several reasons why relying solely on Google Patents can be risky, especially in the context of pharmaceutical patents.
The Pharmacist
DECEMBER 16, 2024
People who smoke both vapes and cigarettes are less likely to quit smoking compared to people who use only cigarettes or only vapes, according to a new study published inERJ Open Research. Dual users (DU), who smoke both conventional cigarettes (CC) and e-cigarettes (EC), were found to be most likely to revert to smoking only […] The post Vaping while smoking is unlikely to help users quit appeared first on The Pharmacist.
Pharma Mirror
DECEMBER 16, 2024
CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased deal-making on site. The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharma Mirror Magazine.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Compounding Pharmacy of America
DECEMBER 16, 2024
Discover the benefits of BHRT, a natural solution for hormone imbalance. Learn how it relieves menopause symptoms, improves energy, and supports overall health. The post The Benefits of Bioidentical Hormone Replacement Therapy (BHRT) appeared first on Compounding Pharmacy of America.
Pharmaceutical Commerce
DECEMBER 16, 2024
A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.
Compounding Pharmacy of America
DECEMBER 16, 2024
Discover how compounding for sports medicine provides athletes with personalized treatments for pain relief, recovery, and performance enhancement. The post A Guide to Compounded Prescriptions for Sports Medicine appeared first on Compounding Pharmacy of America.
PharmExec
DECEMBER 16, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Commerce
DECEMBER 16, 2024
Kevin OMeara discusses how patient service teams influence adherence from Direct-to-Patient models.
PharmExec
DECEMBER 16, 2024
The Breakthrough Therapy Designation for Jemperli was based on Phase II clinical trial data, showing a 100% clinical complete response rate in patients with locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.
Pharmaceutical Technology
DECEMBER 16, 2024
The biopharmaceutical industry faces a future full of risks and rewards. But what role will 3PL suppliers play?
PharmExec
DECEMBER 16, 2024
Approval of Unloxcyt was based on results from the CK-301-101 trial, which showed the drug is the first FDA-approved PD-L1blocking antibody to produce clinically meaningful and durable objective response rates in patients with metastatic or locally advanced cutaneous squamous cell carcinoma.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
DECEMBER 16, 2024
The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged 12 years and above with moderate-to-severe atopic dermatitis.
PharmExec
DECEMBER 16, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
DECEMBER 16, 2024
The latest news for pharma industry insiders.
PharmExec
DECEMBER 16, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaTech
DECEMBER 16, 2024
In the second part of a video interview, Colin McKinlay, PhD, senior director, Chemistry and Delivery Technologies, at Nutcracker Therapeutics, discusses trends and the future direction of mRNALNP development.
Expert insights. Personalized for you.
244 
Let's personalize your content